Global Topical Dressings Market to Reach $1.1 Billion by 2027 - GlobeNewswire
Overview
October 25, 2022 10:52 ET | Source: ReportLinker Lyon, FRANCE New York, Oct. 25, 2022 (GLOBE NEWSWIRE) - Reportlinker.com anounces the release of the report "Global Topical Dressings Industry" - htps:/w.reportlinker.com/p0603142/?utm_source=GNW 6% over the analysis period 20-2027. Burn Wounds, one of the segments analyzed in the report, is projected to record a 10.5% CAGR and reach US$37.5 Milion by the end of the analysis period.
Key Information
Taking into acount the ongoing post pandemic recovery, growth in the Surgical Wounds segment is readjusted to a revised 10.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $140.6 Milion, While China is Forecast to Grow at 14.9% CAGRThe Topical Dressings market in the U.S. is estimated at US$140.6 Milion in the year 20.
China, the world`s second largest economy, is forecast to reach a projected market size of US$29.5 Milion by the year 2027 trailing a CAGR of 14.9% over the analysis period 20 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.4% and 10.1% respectively over the 20-2027 period. Within Europe, Germany is forecast to grow at aproximately 9.3% CAGR.
Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$158.4 Milion by the year 2027.Diabetic foot ulcers Segment to Record 13.6% CAGRIn the global Diabetic foot ulcers segment, USA, Canada, Japan, China and Europe wil drive the 13.6% CAGR estimated for this segment. These regional markets acounting for a combined market size of US$7.7 Milion in the year 20 wil reach a projected size of US$179.9 Milion by the close of the analysis period.
China wil remain among the fastest growing in this cluster of regional markets. Latin America wil expand at a 15.2% CAGR through the analysis period. Select Competitors (Total 12 Featured) - 3M GroupAdvancis Medical LCB.
Summary
Braun Melsungen AgCardinal Health, Inc.Coloplast A/SConva
Frequently Asked Questions
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
Share this article